Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

Zydus Lifesciences Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Download
23 Mar 2024
Zydus receives tentative approval from USFDA for Letermovir Tablets, 240 mg and 480 mg.

Source: BSE India

View all announcements for Zydus Lifesciences Ltd
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com